|
|
Profile
|
Delegates :
President Shigeo Seki |
|
Incorporated :
March 3 , 1938 |
Paid in Capital :
100 Million yen |
Employees :
750 人 |
Address :
1879 Ohyasumi, Iida, Nagano, Japan NAGANO
〒395-8515
|
TEL/FAX :
+81-265-21-1800 / +81-265-21-1861 |
URL：
http://www.tamagawa-seiki.co.jp |
Attachment :
|
Mission/Background :
We strive to become more environment-friendly, to become an enterprise worthy of ever-greater trust by our customers. Since its foundation, Tamagawa Seiki has taken up the challenge of angular precision for control equipment, such as high-precision sensors, motors and gyros, and successfully delivered such equipment to its customers. In 2003, we began R&D for the magnetic nanoparticles in cooperation with Tokyo Institute of Technology. |
|
Technology & Business
|
We are manufacturing and selling the high-performance magnetic nanoparticles (FG beads) used for drug discovery research.
FG beads are used as matrices for affinity purification, and have excellent features as follows, (1) high dispersibility, enabling efficient binding, (2) extremely low level of non-specific protein adsorption, (3) high resistance to organic solvents, enabling various kinds of ligands to be immobilized. One-step purification of drug target protein become possible by the FG beads.
We are also providing various services concerning target protein identification.
|
|
Products & Service
|
Products & Service Name
|
Stage
|
Outline
|
Milestone
|
FG beads (magnetic nanoparticles)
|
Launched
|
research tool used for drug discovery and chemical biology research
|
market expansion
|
contract services
|
Service/Marketing
|
contract service for target protein identification
|
market expansion
|
Fluorescent beads
|
Launched
|
Fluorescent magnetic beads (FF beads) enable rapid and sensitive immunoassays
|
market expansion
|
|
|
|
|
|
|
|
|
|
Highlights
|
Prof. Hiroshi Handa of the Tokyo Institute of Technology and his colleagues identified the target protein of thalidomide using FG beads, and elucidated the mechanism that thalidomide caused birth defects. [Ito, T. et al. Science 327, 1345-1350 (2010)]
|
|
Alliance strategy
|
We are manufacturing and selling FG beads to pharmaceutical companies, bio-ventures, and universities as tools for the drug discovery research. In addition, we will provide various services concerning target protein identification.
|
|
|